J.B. Chemicals & Pharmaceuticals balance sheet

As of Mar 2026

Total assets: ₹4,969cr+16.3% on Mar 2025
Shareholders' equity: ₹4,159cr+21.1% on Mar 2025
Total debt: ₹0.0cr−100.0% on Mar 2025
Cash and investments: ₹849cr+96.5% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	612	610	572	532
	61.2	46.7	63.3	44.4
	57.5	57.5	57.5	57.5
	1,216	1,301	1,375	1,312
	12.8	16.4	13.1	10.7
	26.0	28.0	23.7	13.8
	0.2	0.4	0.6	0.7
	30.2	256	10.0	18.6
	56.4	284	34.3	33.1
	6.9	8.4	5.9	6.5
	—	15.5	4.9	3.4
	2,023	2,339	2,126	1,999
	683	529	503	430
	739	317	365	192
	781	815	687	576
	110	115	88.2	76.9
	35.7	14.4	7.3	1.9
	0.5	0.6	0.7	1.4
	560	14.5	12.7	21.9
	2,226	1,277	1,161	870
	182	117	190	228
	2,946	1,934	1,868	1,555
	4,969	4,274	3,994	3,554
Equity
	16.1	15.6	15.5	15.5
	4,143	3,418	2,908	2,465
	4,159	3,433	2,923	2,480
	3.1	1.0	0.0	0.0
	4,159	3,433	2,923	2,480
Liabilities
	0.0	0.0	23.6	383
	1.1	6.4	9.6	15.3
	1.1	6.4	33.3	399
	29.4	22.5	18.4	15.2
	184	177	149	103
	3.6	1.9	1.7	2.5
	218	208	203	519
	0.0	13.8	334	165
	391	411	356	239
	126	115	93.4	79.7
	517	540	783	483
	65.3	62.3	49.1	42.5
	9.2	8.2	11.8	5.0
	33.1	22.3	24.2	23.7
	591	632	868	554
	809	840	1,071	1,074
	4,969	4,274	3,994	3,554
Assets — additional as-filed lines
	36.7	11.7	15.0	26.7
Trade payables — MSME split
	51.5	37.0	—	—
	339	374	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

JBCHEPHARM

J.B. Chemicals & Pharmaceuticals Ltd.

· Pharma & Health

₹ CrorePeersTORNTPHARM ALKEM IPCALAB SAILIFE NH NEULANDLAB ACUTAAS NATCOPHARM

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Non-current Assets
+ Property, Plant & Equipment	532.0	571.6	609.9	611.6
+ Capital Work-in-Progress	44.4	63.3	46.7	61.2
+ Goodwill	57.5	57.5	57.5	57.5
+ Other Intangibles	1,311.5	1,375.4	1,300.8	1,216.3
+ Intangibles under Development	10.7	13.1	16.4	12.8
+ Non-current Investments	13.8	23.7	28.0	26.0
+ Long-term Loans	0.7	0.6	0.4	0.2
+ Other Non-current Financial Assets	18.6	10.0	255.8	30.2
Non-current Financial Assets	33.1	34.3	284.1	56.4
+ Deferred Tax Assets	6.5	5.9	8.4	6.9
+ Other Non-current Assets	3.4	4.9	15.5	—
Total Non-current Assets	1,999.1	2,125.8	2,339.3	2,022.6
Current Assets
+ Inventories	430.5	502.5	529.0	683.4
+ Current Investments	192.2	364.7	317.1	738.9
+ Trade Receivables	575.8	686.9	815.4	780.9
+ Cash & Cash Equivalents	76.9	88.2	115.1	110.2
+ Other Bank Balances	1.9	7.3	14.4	35.7
+ Short-term Loans	1.4	0.7	0.6	0.5
+ Other Current Financial Assets	21.9	12.7	14.5	559.7
Current Financial Assets	870.0	1,160.5	1,277.0	2,226.0
+ Other Current Assets	227.5	190.3	116.8	182.2
Total Current Assets	1,554.8	1,868.3	1,934.5	2,946.0
Total Assets	3,553.9	3,994.1	4,273.8	4,968.7
Equity
+ Equity Share Capital	15.5	15.5	15.6	16.1
+ Other Equity / Reserves	2,464.9	2,907.8	3,417.8	4,143.2
Equity — Owners of Parent	2,480.4	2,923.3	3,433.3	4,159.2
+ Minority Interest	0.0	0.0	1.0	3.1
Total Equity	2,480.4	2,923.3	3,433.3	4,159.2
Liabilities
+ Borrowings — Non-current	383.2	23.6	0.0	0.0
+ Other Non-current Financial Liab	15.3	9.6	6.4	1.1
Non-current Financial Liabilities	398.5	33.3	6.4	1.1
+ Provisions — Non-current	15.2	18.4	22.5	29.4
+ Deferred Tax Liabilities	102.8	149.2	177.3	184.2
+ Other Non-current Liabilities	2.5	1.7	1.9	3.6
Non-current Liabilities	519.1	202.6	208.1	218.3
+ Borrowings — Current	165.0	333.5	13.8	0.0
+ Trade Payables	238.6	356.3	410.7	391.0
+ Other Current Financial Liab	79.7	93.4	115.0	125.7
Current Financial Liabilities	483.3	783.2	539.6	516.7
+ Provisions — Current	42.5	49.1	62.3	65.3
+ Current Tax Liabilities	5.0	11.8	8.2	9.2
+ Other Current Liabilities	23.7	24.2	22.3	33.1
Current Liabilities	554.5	868.2	632.3	591.2
Total Liabilities	1,073.5	1,070.8	840.5	809.4
Total Equity & Liabilities	3,553.9	3,994.1	4,273.8	4,968.7
Assets — additional as-filed lines
+ Current Tax Assets	26.7	15.0	11.7	36.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	37.0	51.5
+ Dues to Other Creditors — Current	—	—	373.7	339.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.